Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance

by Sofia Ajeganova, Ann De Becker, Rik Schots
Published 2020-11-01

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort

by Ingiäld Hafström, Sofia Ajeganova, Kristina Forslind, Björn Svensson
Published 2019-02-01

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

by Sofia Ajeganova, Maria L. E. Andersson, Johan Frostegård, Ingiäld Hafström
Published 2021-07-01

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms

by Johan Frostegård, Sabbir Ahmed, Ingiäld Hafström, Sofia Ajeganova, Mizanur Rahman
Published 2021-01-01

Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower...

by Thomas Gustafsson, Sofia Ajeganova, Linnea Lindberg, Ingiäld Hafström, Johan Frostegård
Published 2020-12-01

Effects of Atorvastatin on T‐Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C‐Reactive Protein and Interleukin 6

by Jitong Sun, Pritam Kumar Panda, Shailesh Kumar Samal, Rajeev Ahuja, Sofia Ajeganova, Ingiäld Hafström, Anquan Liu, Johan Frostegård
Published 2021-09-01

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical

by Debbie M. Boeters, Lukas Mangnus, Sofia Ajeganova, Elisabet Lindqvist, Björn Svensson, René E. M. Toes, Leendert A. Trouw, Tom W. J. Huizinga, Francis Berenbaum, Jacques Morel, Solbritt Rantapää-Dahlqvist, Annette H. M. van der Helm-van Mil
Published 2017-05-01